“…A notable limitation is that the samples used in this study represented nasopharyngeal cells; however, ACE2 is highly expressed in the human body ( Hamming et al., 2007 ; Hikmet et al., 2020 ), with abundant expression in the heart and small intestine tissues ( Hikmet et al., 2020 ; Li et al., 2020 ), as well as the adipose tissue, where the harmful effects of ang II are present in the form of inflammation and adipogenesis ( Ting et al., 2023 ). Because ACE2 is widely expressed in human tissues ( Hamming et al., 2004 ; Ni et al., 2020 ; Beyerstedt et al., 2021 ), the potential effects of lower or higher ACE2 expression may occur within other tissues, possibly influencing COVID-19 symptoms, considering that it infects such important tissues to maintain homeostasis ( Wu et al., 2020 ; Gasmi et al., 2021 ).…”